Test-retest reliability of the StepWatch Activity Monitor outputs in individuals with chronic stroke by Mudge, S & Stott, NS
 1 
Test-Retest Reliability of the StepWatch Activity Monitor Outputs in Individuals 
with Chronic Stroke 
 
Suzie Mudge, MHSc; N. Susan Stott, PhD 
 
Department of Surgery, University of Auckland 
 
Address for correspondence: Suzie Mudge, Department of Surgery, University of 
Auckland, Private Bag 92019, Auckland 1142, New Zealand. Phone: 64 9 373 
7599 X 85387, Fax: 64 9 367 7159, e-mail: s.mudge@auckland.ac.nz.    
 
 2 
Test-Retest Reliability of the StepWatch Activity Monitor Outputs in Individuals 
with Chronic Stroke 
 
Abstract 
 
Objective:  To examine the test-retest reliability of the StepWatch Activity 
Monitor outputs over two periods a week apart in participants with stroke.  
Design: Test-retest reliability study over monitoring periods of one, two and 
three days 
Setting: Participant’s usual environment 
Participants: Forty participants more than six months post stroke. 
Main measures: StepWatch outputs: total step count, number of steps at high 
medium and low stepping rates, sustained activity indices, peak activity index.  
Results: The Intraclass Correlation Coefficients were high for all StepWatch 
outputs and all monitoring periods but were highest for the three day monitoring 
period (0.930-0.989) and lowest for the one day monitoring period (0.830-
0.950). The coefficient of variation ranged from 6.7-48.7% over the monitoring 
periods, with higher variation shown for shorter monitoring periods. The most 
reliable four outputs had 95% limits of agreement between three day periods 
that were less than 40%. These were total step count (37.8%), highest step 
rate in one minute (23.0%), highest step rate in five minutes (38.6%) and 
peak activity index (29.8%). The highest step rate in one minute was the only 
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StepWatch output that had 95% limits of agreement less than 40% for the two 
day (31.2%) and one day (36.7%) monitoring periods. 
Conclusions: Total step count, highest step rate in one minute, highest step 
rate in five minutes and peak activity index have good test-retest reliability over 
a three day monitoring period, with lower reliability shown by the other 
StepWatch outputs. In general, monitoring over one or two days is less reliable. 
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Stroke is the most common cause of severe disability in adults1. Although 70% of 
people with stroke are able to walk independently in a clinical setting2, fewer 
walk independently in the community3. In line with current recommendations4, 
the focus is shifting from clinic based measures to measures of walking in usual 
environments5, such as activity monitoring. One such monitor is the StepWatch 
Activity Monitor6, which consists of an accelerometer and microprocessor. The 
StepWatch can be worn on the ankle for extended periods and has a range of 
outputs available.  
 
Total step count is the most commonly used output, but sustained activity 
measures are also available for 1, 5, 20, 30 and 60 minutes. These measures are 
calculated by scanning the accumulated 24 hour data to determine the maximum 
number of steps taken during continuous intervals of 1, 5, 20, 30 and 60 
minutes.  The peak activity index represents the average step rate of the fastest 
30 minutes over 24 hours, regardless of when they occurred. The peak activity 
index is thus a non-continuous interval in contrast to the sustained activity 
indices which are continuous intervals. The number of steps at high (above 60 
steps/min), medium (between 30 and 60 steps/min) and low (below 30 
steps/min) step rates can also be calculated.  
 
Of all the available outputs, only total step count has been tested for test-rest 
reliability in the stroke population7, 8. These two studies reported excellent test-
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retest reliability with Intraclass Correlation Coefficients above 0.96. One study 
used the StepWatch over a short period of less than an hour7 but the other 
monitored participants for two days8. Although these results are promising, the 
current literature provides little guidance for clinicians or researchers regarding 
the optimal monitoring period in patients with stroke or information on the 
reliability of many of the available StepWatch outputs. Thus, the major aim of 
this study was to assess the test-retest reliability of the StepWatch outputs (total 
step count, peak activity index, sustained activity indices of 1, 5, 20, 30, 60 
minutes, steps at high, medium and low stepping rates) over two three day 
periods at least one week apart in subjects with chronic stroke. A secondary aim 
was to assess test-retest reliability over shorter monitoring periods of one day 
(the first day of each three day monitoring period) and two days (the first two 
days of each three day monitoring period). 
 
Methods  
 
A convenience sample of 40 individuals with chronic stroke was recruited from 
the hospital stroke service and newspaper advertising. Subjects were eligible for 
inclusion if they were at least six months post stroke, were able to walk 
independently but with some residual difficulty confirmed by the physical 
functioning scale of the 36 Item Short Form Health Survey9 and walked in the 
community at least once a week. Individuals were excluded if they had fallen 
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more than twice in the previous six months, had another serious health problem 
affecting walking or if they were unable to complete the testing for another 
reason. All participants gave written informed consent, and the study was 
approved by the Northern Regional Ethics Committee. 
 
All subjects attended the Neuro Rehab Results clinic for initial testing. A 
StepWatch activity monitor (Orthocare Innovations, 6405 218th St SW, Suite 
100, Mountlake Tce, WA 98043-2180, US) was calibrated and attached to the 
lateral side of the ankle of the non-paretic leg with a strap or cuff. The sensitivity 
and cadence settings were adjusted for each participant so that the monitor 
recognised every step during fast, slow and self selected walking speeds. Self-
selected gait speed was tested over 10 metres10 and the Rivermead Mobility 
Index11 was administered. 
 
Subjects were instructed to wear the monitor for three days and for the same 
three days the following week, removing it for sleeping and showering. Subjects 
were given an instruction sheet with details about the care of the StepWatch and 
a follow up appointment was made to pick up the monitor. 
 
Statistical analyses 
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Intraclass correlation coefficients (ICC) were calculated to assess test-retest 
reliability between the means of each three day period for each StepWatch 
output. An ICC of above 0.75 was considered to indicate excellent test-retest 
reliability12. The 95% limits of agreement between the means of each three day 
period for each StepWatch output were also calculated as a coefficient of 
repeatability13. Bland and Altman advocate plotting the difference between the 
two measurements against the mean of the two measurements for each subject 
and calculate 95% limits of agreement as the range of differences falling within 
the mean difference  1.96 standard deviations13, 14. The 95% limits of 
agreement represent the repeatability of the measure from week to week and 
can be expressed either as absolute numbers or percentage differences between 
the first and second testing sessions. In this paper, the 95% limits of agreement 
are reported both as absolute numbers and percentage differences to allow 
comparison of repeatability between the different outputs.  
 
The coefficient of variation was also calculated (standard deviation expressed as 
a percentage of the mean) between the means of each three-day period15. 
 
To assess the reliability of one and two day monitoring periods, the same 
statistical tests were used to determine the level of agreement between the first 
day and the first two days of each monitoring period.  
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Bland-Altman calculations were performed using GraphPad Prism (Version 4.03; 
GraphPad Software Inc, 11452 El Camino Real, #215 San Diego, CA 92130, US), 
ICCs were calculated by SPSS (Version 14.0.0; SPSS Inc. Headquarters, 233 S. 
Wacker Drive, Chicago, IL 60606, US) and the coefficient of variation was 
calculated in Excel 2003 (Microsoft Corporation, One Microsoft Way, Redmond, 
WA 98052-7329, US). 
 
Results 
 
Fifty-four participants enrolled in the study. One participant withdrew during the 
testing period due to an unrelated medical complication. A further 13 participants 
were excluded from the analysis as they did not wear the StepWatch for six 
complete days. The remaining 40 participants with a mean (SD) age of 69.2 
(12.6) years completed the study. There were 23 men and 17 women with a 
mean (SD) 5.1 (5.1) years after stroke. Fifteen participants had right sided 
paresis. The mean (SD) gait speed was 0.67 (0.34) m/s. All participants walked 
independently with a mean (SD) score of 13 (1.8) on the Rivermead Mobility 
Index. The mean and standard deviation of each StepWatch output are shown in 
Table 1. 
 
<Table 1> 
 
 9 
ICCs were generally high for all StepWatch outputs and all monitoring periods 
but were lowest for the one day monitoring period (Table 1). The ICCs ranged 
from 0.830-0.989, indicating excellent test-retest reliability. 
 
The coefficient of variation ranged from 6.7-37.6% for the three day period, 8.4-
43.9% for the two day period and 8.5-48.7% for the one day period, indicating 
more variation with a shorter monitoring period (Table 1). 
 
Bland Altman analysis showed that the four most reliable outputs had 95% limits 
of agreement between three day periods that were less than 40% (Table 1). 
These were total step count (37.8%), highest step rate in one minute (23.0%) 
(Figure 1A), highest step rate in 5 minutes (38.6%) and peak activity index 
(29.8%). The seven other StepWatch outputs had 95% limits of agreement 
between three day periods greater than 40% (48.4-153.3%). Figure 1B shows 
the Bland Altman plot for three day test-retest reliability for highest step rate in 
30 minutes as an example of wide limits of agreement. The highest step rate in 
one minute was the only StepWatch output that had 95% limits of agreement 
less than 40% for the two day monitoring period (31.2%) and for the one day 
monitoring period (36.7%). 
  
Discussion 
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This study has shown that three day monitoring of total step count by the 
StepWatch shows excellent test-retest reliability, with an ICC of 0.989 and 95% 
limits of agreement of less than 40%. Three other StepWatch outputs (highest 
step rate in one minute, peak activity index and highest step rate in five minutes) 
also have high ICCs and 95% limits of agreement less than 40% when measured 
over three days. This suggests that these are also reliable outputs for a three 
day monitoring period. In contrast, the variation of the majority of StepWatch 
outputs over one or two days is higher, indicating lower reliability with shorter 
monitoring periods. 
 
Our results of monitoring over three days compare favourably to the study of 
seven day monitoring by Busse et al16 and suggest that a three day monitoring 
period of total step count appears to be at least as reliable as a seven day 
monitoring period. Although the ICCs were high for total step count over the two 
and one day monitoring periods and comparable to previous work in stroke7, 8, 
the 95% limits of agreement for total step count revealed considerable day to 
day variability. Thus we would advocate at least a three day monitoring period 
for total step count. 
 
Both the highest step rate in one minute and the peak activity index had better 
test-retest reliability than total step count over a three day monitoring period in 
this study. The lower reliability of total step count may, in part, be due to the 
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natural variation that occurs from day to day. Besides physical capacity, there 
are other potential influences on the total steps an individual takes in one day. 
For example, it is likely that behavioural, personal, environmental and social 
factors also impact the number of steps taken in one day. Highest step rate in 
one minute and peak activity index are both based on rate rather than amount of 
stepping and may be more reflective of maximal physical performance. 
 
Of all the measures, the highest step rate in one minute has the best test-retest 
reliability and the lowest coefficient of variation over three days. The daily 
variability is also low. Therefore, this output could be used if it were only possible 
to monitor for a day. The high daily variation for all other StepWatch outputs is 
similar to the findings of Busse et al16 and we would concur that the variation in 
most StepWatch outputs is too high for one day to be recommended as a 
monitoring period.  
 
Reliability studies provide important direction for clinicians, who need to 
determine how much change in a measure following an intervention is required 
to reflect a true change. 95% limits of agreement derived from Bland Altman 
analyses provide one estimate of true change and frequently highlight variability 
not apparent with ICCs. In general, wide limits of agreement for the same 
measure between different weeks means that, either changes due to an 
intervention will be obscured by the measurement variability (caused by 
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measurement inaccuracy or natural daily subject variability) or, alternatively, 
changes due to the variability of the measure will be misinterpreted as a true 
change in the patient. In this study, we have selected activity measures that are 
repeatable to within 40% as outputs that are more clinically relevant based on 
other studies that have shown changes of up to 40% in other parameters such 
as gait velocity after exercise programmes in subjects with stroke17. However, 
this does not rule out use of SAM outputs with higher variability as long as the 
variability is recognised.  
 
Of note, Hopkins argues that 95% limits of agreement are too large to use as a 
threshold for deciding if a true change has occurred. Instead he suggests that 
1.5 to 2.0 times the typical error (or coefficient of variation) as a more realistic 
threshold15. If we use 2.0 as the more conservative estimate of true change, 
then at least a 21% change in total step count and highest step rate in five 
minutes, 14% in highest step count in one minute and 16% in peak activity 
index represent a true change over a three day monitoring period. 
 
The clinical relevance of activity monitoring is also an important question. In 
individuals with stroke, total step count is correlated to gait speed18, the FIM 
motor score19 and the Berg Balance Scale (r=0.58)18. In patients with other 
neurological conditions, total step count correlates to the physical functioning 
index of the 36 Item Short Form Health Survey20 and the Rivermead Mobility 
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Index21. However, there is no published work investigating the relationship 
between the other StepWatch outputs and clinical tests. The high test-retest 
reliability of the highest step rate in one minute, peak activity index and highest 
step rate in five minutes supports the need for further work in this area to 
investigate the clinical relevance of these additional outputs. 
 
Another limitation of the use of sustained activity indices is that there is little 
information published about normal values. Busse et al reported a mean peak 
activity index of 59 steps/minute in ten healthy subjects, but did not report on 
highest step rate in one minute16. The authors did comment that the sustained 
activity indices were more variable in a healthy population, compared to patients 
with neurological disorders. Further research is needed to establish normal 
values for the activity indices. 
 
The results of this study are limited in their applicability to those with chronic 
stroke who are able to walk independently and who walk in the community at 
least once weekly. Thus the findings may not apply to those with more limited 
mobility or acute stroke. Likewise the results may not apply to those with a 
diagnosis other than stroke. It is recommended that reliability is assessed in 
other population groups. 
 
Clinical Messages 
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 Total step count has excellent test-retest reliability when used for three days 
in individuals with stroke.  
 Highest stepping rate in one minute is the most reliable output of the 
StepWatch. 
 Monitoring for less than a three day period is not recommended due to high 
variability. 
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Table 1. Mean, standard deviation and reliability statistics for SAM outputs for one day, two day and three day periods one week apart.
SAM output Mean (SD) ICC Coefficient of variation (%) 95% limits of agreement*
day 1 days 1 & 2 all 3 days day 1 days 1 & 2 all 3 days day 1 days 1 & 2 all 3 days
Total step count 6247 (4439) 0.928 0.986 0.989 22.1 14.9 10.7 2507 (91.1) 2028 (62.0) 1801 (37.8)
Number of steps at medium rate (>30 and <60 steps/minute) 2241 (1681) 0.950 0.978 0.984 31.8 22.5 17.8 1549 (139) 988 (101) 836 (87.1)
Number of steps at high rate (>60 steps/minute) 1614 (2252) 0.873 0.971 0.926 48.7 43.9 37.6 3401 (186) 1449 (206) 1750 (153)
Number of steps at medium and high rate (>30  steps/minute) 3855 (3604) 0.923 0.985 0.969 35.2 24.1 20.9 4147 (148) 1673 (109) 1814 (90.7)
Number of steps at low rate (>30 steps/minute) 2338 (1051) 0.871 0.940 0.953 18.5 14.6 11.1 1777 (75.0) 1112 (53.0) 1643 (63.6)
Peak activity index (steps/min) 58 (22) 0.861 0.953 0.955 12.8 9.4 7.9 34.7 (60.6) 19.7 (43.4) 18.7 (29.8)
Highest step rate in 60 minutes (max 60) (steps/min) 25 (18) 0.852 0.948 0.957 25.7 18.9 14.8 31.5 (104) 15.3 (75.3) 14.2 (55.0)
Highest step rate in 30 minutes (max 30) (steps/min) 33 (20) 0.889 0.940 0.939 21.5 16.3 14.4 30.3 (91.5) 19.2 (62.8) 19.7 (52.8)
Highest step rate in 20 minutes (max 20) (steps/min) 39 (22) 0.903 0.929 0.930 19.3 15.2 13.5 31.6 (81.0) 23.7 (55.9) 23.4 (48.4)
Highest step rate in 5 minutes (max 5) (steps/min) 59 (24) 0.830 0.918 0.934 16.0 12.4 10.2 41.9 (63.9) 27.6 (47.9) 24.5 (38.6)
Highest step rate in 1 minute (max 1) (steps/min) 81 (25) 0.912 0.941 0.964 8.5 8.4 6.7 29.9 (36.7) 23.7 (31.2) 18.3 (23.0)
* expressed as absolute value (percentage)
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Figure 1A&B. Bland-Altman plot with 95% limits of agreement expressed as 
percentages for a three day monitoring period of (A) highest step rate in one 
minute and (B) highest step rate in 30 minutes. 
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